Tuesday, March 21, 2017

Constraints simplex] Nitto pharmaceutical, lab jikyu brand extension 外



Nitto Pharmaceutical, probiotics brand jikyu rap 'New Release

The probiotic brand jikyu wrap 'all members of the new constraints introduced three kinds. The new product is released △ BP also jikyu rap rap Bebe Plus △ △ jikyu jikyu Lab Kids Chewable tablet. "BP also jikyu Lab Plus is a product consisting of around 10 billion probiotic bifidobacteria are mainly distributed in the chapter. "Jikyu wrap Bebe" has added the design of products and billion probiotics and zinc center, a colostrum powder and additives such as DHA for children. "Jikyu Lab Kids Chewable tablet 'is contained billion probiotics and zinc mainly required for normal immune function of colostrum powder additives such as vitamins B · C, which can help smooth bowel activity.

Guangdong Pharmaceutical Kaepung gyeongokgo 'male infertility prevention and treatment, Japanese Patent

Kaepung gyeongokgo of Guangdong Pharmaceutical's it going to ensure that there is effective prevention and treatment of male infertility were registered patent from the Japanese Patent Office. Kaepung gyeongokgo Guangdong Pharmaceutical products are being exported to Japan, weakness, physical fatigue, taking a chance circle with a restorative effects such as decreased physical illness. Since 1981, exports to Japan gotta boasts a history of over 30 years and interest is hot enough to cause a meeting of more than 500 pharmacists are called "jadeite time" to study the gyeongokgo. Guangdong Pharmaceutical progress in the past since December 2011, one years, Kyung Hee University College of Pharmacy ohmyeongsuk the theme of the relationship between Kaepung gyeongokgo and male infertility through the team 'male infertility Kaepung gyeongokgo improved efficacy in vivo experiments' commissioned research for this patent did.

Financial Daily Economic News FNTIMES - unauthorized reproduction for commercial purposes in accordance with the Copyright Act, No copying, distribution,
Copyright ⓒ Korea's financial newspaper & FNTIMES.com